Scientists have reported a major breakthrough suggesting that honeybee venom may offer a potent new approach to treating aggressive forms of breast cancer. According to the findings, the venom was able to eliminate nearly all aggressive breast cancer cells in laboratory tests within an hour.
The research highlights melittin, a naturally occurring compound found in honeybee venom but absent in bumblebee venom, as the key agent responsible for this effect. Laboratory experiments showed that melittin attacks cancer cells by creating pores in their membranes, leading to rapid cell death.
Importantly, the scientists noted that melittin left healthy cells mostly unaffected, raising hope that future treatments based on this compound could cause fewer side effects compared to conventional chemotherapy or radiation therapies.
The compound was especially effective against triple-negative breast cancer and HER2-enriched breast cancer, two types known for their resistance to standard treatment options. Researchers say these findings could pave the way for more targeted and less toxic cancer therapies derived from natural sources.
Work is now underway to explore how melittin can be safely and effectively delivered, with scientists considering options such as nanoparticles or synthetic versions of the molecule. Although further research and clinical trials are required, experts believe this development could introduce a promising new weapon in the fight against cancer.
